awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33398044-DCE6D8EA-148D-4A10-9B83-368029C9C44E
Q33398044-DCE6D8EA-148D-4A10-9B83-368029C9C44E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33398044-DCE6D8EA-148D-4A10-9B83-368029C9C44E
The clinical safety of lenalidomide in multiple myeloma and myelodysplastic syndromes.
P2860
Q33398044-DCE6D8EA-148D-4A10-9B83-368029C9C44E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33398044-DCE6D8EA-148D-4A10-9B83-368029C9C44E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
56a2bf1039bf71c4d487b005c4655b4ed692b263
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.